|
US2005220754A1
|
|
Vitamin directed targeting therapy
|
|
AUPR702201A0
|
|
Enhancement of vitamin b12 targeting through co-administration of vitamin b12 analogues
|
|
AUPR702101A0
|
|
Enhancement of vitamin b12 targeting through co-administration of asialoglycoprotein receptor blockers
|
|
AUPR702001A0
|
|
Enhancement of vitamen B12 targeting through co-administration of transcobalaminII
|
|
AUPR638101A0
|
|
Composition and method for treatment of disease
|
|
AUPR526401A0
|
|
Amplification of the oral delivery of growth hormone using polymers
|
|
AU1119501A
|
|
Protease inhibitors as modulators of periodontal wound healing
|
|
AUPQ867400A0
|
|
Modification of serum properties of pharmaceuticals with bacterial polysaccharides
|
|
AUPQ582400A0
|
|
A method of treatment and agents for use therein
|
|
AU1071200A
|
|
Systems for oral delivery
|
|
AUPQ256299A0
|
|
Novel bis-amides
|
|
AU5298399A
|
|
Protease inhibitors for use in the treatment of psoriasis
|
|
AUPQ168899A0
|
|
Anti-tumour agents
|
|
AUPQ146299A0
|
|
Modification of serum properties of pharmaceuticals with bacterial polysaccharides
|
|
AU4490099A
|
|
Vitamin B12 derivatives and methods for their preparation
|
|
AUPQ071299A0
|
|
Vitamin directed dual targeting therapy
|
|
AUPQ014699A0
|
|
Amplification of folate-mediated targeting to tumor cells using nanoparticles
|
|
AUPQ014799A0
|
|
Amplification of folate-mediated targeting to tumor cells using polymers
|
|
US6406873B2
|
|
PAI-2 and T-PA as diagnostic markers of periodontal disease
|
|
IL138594D0
|
|
Use of protease inhibitors for treating skin wounds
|
